Skip to main content

Search Results

out of 5 results
DAWN | Drug Abuse Warning Network
Collected Date: 2022
Report Type: Annual Report

An analysis of the 2022 DAWN data presents: (1) nationally representative weighted estimates of all drug-related emergency department (ED) visits, (2) nationally representative weighted estimates of the top substances involved in drug-related ED visits, including rates by race and ethnicity; (3) nationally representative weighted estimates of opioid-related ED visits...

DAWN | Drug Abuse Warning Network
Collected Date: 2021
Report Type: Annual Report

An analysis of final 2021 DAWN data presents: (1) nationally representative weighted estimates, including percent and unadjusted rates per 100,000, for all drug-related ED visits, (2) nationally representative weighted estimates for the top five drugs in drug-related ED visits, (3) the assessment of monthly trends and drugs involved in polysubstance...

DAWN | Drug Abuse Warning Network
Collected Date: 2021
Report Type: Annual Report

Preliminary Findings from Drug-Related Emergency Department Visits, 2021. An analysis of 2021 preliminary data presents (1) nationally representative weighted estimates for the top five drugs in drug-related ED visits, (2) the assessment of monthly trends and drugs involved in polysubstance ED visits in a subset of sentinel hospitals, and (3)...

DAWN | Drug Abuse Warning Network
Collected Date: 2005-2011
Report Type: Spotlight

This Drug Abuse Warning Network (DAWN) spotlight is about emergency department visits involving nonmedical use of central nervous system stimulants among adults age 18 to 34 increase between 2005 and 2011.

DAWN | Drug Abuse Warning Network
Collected Date: 2010
Report Type: Spotlight

This Drug Abuse Warning Network (DAWN) spotlight is about emergency department visits involving nonmedical use of phamaceuticals by gender among older adolescents age 12 to 17 from year 2010.